
South and Central America Artificial Cervical Intervertebral Disc Market
No. of Pages: 98 | Report Code: BMIRE00025528 | Category: Life Sciences
No. of Pages: 98 | Report Code: BMIRE00025528 | Category: Life Sciences
Companies in the artificial cervical intervertebral disc market are undertaking many research and development activities to introduce innovative products. The new replacement therapies enable the adoption of advanced technologies, strengthening the procedural outcomes. For instance, in April 2021, UD FDA approved NuVasive Simplify Cervical Artificial Disc for two-level cervical total disc replacement (cTDR).
Additionally, in August 2020, Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, received the US Food and Drug Administration (US FDA) approval for its M6-C artificial cervical disc for patients suffering from cervical disc degeneration. The M6-C artificial cervical disc, a next-generation artificial disc, is developed to replace an intervertebral disc damaged by cervical disc degeneration, which also restores physiologic motion to the spine. Moreover, in May 2018, Zimmer Biomet received approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for its Mobi-C Cervical Disc for cervical total disc replacement (cTDR). Mobi-C is the first cervical disc prosthesis approved by the US FDA to reconstruct a cervical disc at one and two levels (C3-C7). Such robust developments are likely to reshape the artificial cervical intervertebral disc market during the forecast period.
Strategic insights for the South and Central America Artificial Cervical Intervertebral Disc provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 107.89 Million |
Market Size by 2028 | US$ 279.70 Million |
Global CAGR (2021 - 2028) | 17.2% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By Material
|
Regions and Countries Covered | South and Central America
|
Market leaders and key company profiles |
The geographic scope of the South and Central America Artificial Cervical Intervertebral Disc refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The South & Central America artificial cervical intervertebral disc market is analyzed on the basis of material, end user, and country. Based on material, the market has been bifurcated into biopolymer and metal. In 2022, the biopolymer material segment held a larger market share. Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and others. In 2022, the hospitals segment held the largest market share.
Based on country, the market is fragmented into Brazil, Argentina, and the Rest of South & Central America. Brazil will hold the largest market share by the end of 2022.
B. Braun Melsugen AG.; Globus Medical, Inc.; Medtronic; NuVasive, Inc.; Orthofix Medical, Inc.; and Zimmer Biomet Holdings, Inc. are the leading companies in the South & Central America artificial cervical intervertebral disc market.
The South and Central America Artificial Cervical Intervertebral Disc Market is valued at US$ 107.89 Million in 2022, it is projected to reach US$ 279.70 Million by 2028.
As per our report South and Central America Artificial Cervical Intervertebral Disc Market, the market size is valued at US$ 107.89 Million in 2022, projecting it to reach US$ 279.70 Million by 2028. This translates to a CAGR of approximately 17.2% during the forecast period.
The South and Central America Artificial Cervical Intervertebral Disc Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Artificial Cervical Intervertebral Disc Market report:
The South and Central America Artificial Cervical Intervertebral Disc Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Artificial Cervical Intervertebral Disc Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Artificial Cervical Intervertebral Disc Market value chain can benefit from the information contained in a comprehensive market report.